Nanomaterials for Clinical Applications
Case Studies in Nanomedicines
- 1st Edition - February 15, 2020
- Latest edition
- Editors: Costas Demetzos, Natassa Pippa
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 6 7 0 5 - 2
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 6 8 7 6 - 9
Nanomaterials in Clinical Medicine: Case Studies in Nanomedicines focuses on the nanomaterials that can be formulated as drug delivery vehicles, such as liposomes, micelles,… Read more
Nanomaterials in Clinical Medicine: Case Studies in Nanomedicines focuses on the nanomaterials that can be formulated as drug delivery vehicles, such as liposomes, micelles, nanoemulsions and nanogels. Their physicochemical, morphological, thermo-dynamical and nanotoxicological properties are analyzed with respect to the design and development of drug delivery nanosystems for the encapsulation of an active pharmaceutical ingredient and its controlled release. Each chapter covers basic properties, the nanosystem (e.g., liposomes), the added value in drug delivery and targeting, and future perspectives. Case studies and examples of how nanomaterials are being used in clinical medicine, including marketed liposomal medicines and medical utility and regimens are also included.
Particular attention is given to new nanocarriers, such as elastic liposomes, lipid polymeric hybrid nanoparticles, organogel, nanofibers carbon nanomaterials, quantum dots and inorganic nanoparticles. This book is an important information source for those wanting to increase their understanding of what major nanomaterials are being used to create more effective drug delivery systems.
- Summarizes the major nanomaterials used in clinical medicine, explaining how their properties make them suitable for this purpose
- Explains how nanomaterials are used to create increasingly efficient drug delivery vehicles
- Includes real-life examples, demonstrating how nanomaterials are being used in medical practice
Materials Scientists, Biomedical Scientists, and Pharmaceutical Scientists.GRANT: $1,500 to Series Editor in line with Series Editor contract
1. Solid lipid nanoparticles in dermaceuticals
2. Cyclodextrin-based drug-delivery systems
3. Lipid vesicles for (trans)dermal administration
4. Stimuli-responsive nanocarriers for drug delivery
5. Biodegradable nanomaterials
6. Modulating the immune response with liposomal delivery
7. Recent advances in solid lipid nanoparticles formulation and clinical applications
8. Biopolymers, liposomes, and nanofibers as modified peroral drug release formulants
9. Grafted polymethacrylate nanocarriers in drug delivery
- Edition: 1
- Latest edition
- Published: February 15, 2020
- Language: English
CD
Costas Demetzos
Costas Demetzos is Professor, Pharmaceutical Nanotechnology and Director in the Laboratory of Pharmaceutical Technology, Department of Pharmacy at the National and Kapodistrian University of Athens, Greece. His research focuses in the area of pharmaceutical nanotechnology.
Affiliations and expertise
Professor, Pharmaceutical Nanotechnology and Director, Laboratory of Pharmaceutical Technology, Department of Pharmacy, National and Kapodistrian University of Athens, Athens, GreeceNP
Natassa Pippa
Dr. Natassa Pippa is an Assistant Professor in the Department of Pharmaceutical Technology at the National and Kapodistrian University of Athens, Greece. Her research focuses on pharmaceutical technology, specifically the design and development of nanoparticles, such as liposomes, micelles, and hydrogels, for drug delivery and targeting. She completed her master's degree in "Industrial Pharmacy" in 2012 and her PhD thesis in 2015 at the Department of Pharmacy, University of Athens.
Dr. Pippa has been awarded three scholarships for postdoctoral research in Greece and France. She has collaborated with the pharmaceutical industry in the development of drugs, cosmetics, and nutritional supplements.
Affiliations and expertise
Assistant Professor, National and Kapodistrian University of Athens, GreeceRead Nanomaterials for Clinical Applications on ScienceDirect